Aspen cuts debt and plans to reintroduce dividends
Pharmaceutical manufacturer reports headline earnings up 11% and is on track with plans to produce Johnson & Johnson’s vaccine
11 March 2021 - 19:27
SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, said on Thursday that it has continued to cut its debt, is on track with its plans to produce Johnson & Johnson’s (J&J’s) coronavirus vaccine and is committed to reintroducing dividends.
Aspen was among a host of companies that scrapped dividends last year as it sought to preserve cash amid the uncertainty created by the coronavirus pandemic...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.